DC isoketal-modified proteins activate T cells and promote hypertension
Annet Kirabo(Vanderbilt University), David G. Harrison(Vanderbilt University Medical Center), Alfiya Bikineyeva(Vanderbilt University), Venkataraman Amarnath(Vanderbilt University), Meena S. Madhur(Indiana University School of Medicine), Cristi L. Galindo(Instituto de Investigación Biosanitaria de Granada), Ana Paula de Faria(Universidade Estadual de Campinas (UNICAMP)), Raymond L. Mernaugh(Vanderbilt University), Tomasz J. Guzik(Jagiellonian University), Vanessa Fontana(Universidade Estadual de Campinas (UNICAMP)), Fernando Elijovich(New York Medical College), Hana A. Itani(Regeneron (United States)), Mohamed A. Saleh(Mansoura University), Heitor Moreno(Universidade Estadual de Campinas (UNICAMP)), Sean S. Davies(Vanderbilt University), Jing Wu(Nanjing Medical University), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Yu Shyr(Vanderbilt University), Antony Vinh(La Trobe University), Roxana Loperena(Vanderbilt University), Xiao Z. Shen(Cedars-Sinai Medical Center), Liang Xiao(Tianjin Medical University), Jackson Roberts(Vanderbilt University), Daniel W. Trott(Vanderbilt University), Sergey Dikalov(Vanderbilt University Medical Center), Wei Chen(Vanderbilt University), Cheryl L. Laffer(Vanderbilt University Medical Center), Kalyani Amarnath(Vanderbilt University), Kenneth E. Bernstein(Cedars-Sinai Medical Center)
Cited by 533
Related Papers
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
|Journal of Clinical Investigation|1996|2.4k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
|Circulation Research|2001|1.2k